CME
50
-5
AEP
61
2
SYK
60
7
HCA
57
4
PCG
83
2
CTSH
50
3
WRK
79
3
ACN
42
4
PDCO
49
3
DHI
57
7
A
58
3
RRC
70
2
WYNN
38
-2
HAS
46
-4
BA
48
-4
LEN
67
7
ADM
36
-4
EXR
59
4
LH
58
2
M
48
-5
CME
50
-5
AEP
61
2
SYK
60
7
HCA
57
4
PCG
83
2
CTSH
50
3
WRK
79
3
ACN
42
4
PDCO
49
3
DHI
57
7
A
58
3
RRC
70
2
WYNN
38
-2
HAS
46
-4
BA
48
-4
LEN
67
7
ADM
36
-4
EXR
59
4
LH
58
2
M
48
-5
Financhill
Back

Bangkok Dusit Medical Services PCL Quote, Financials, Valuation and Earnings

Sell
38

BDUUY
Bangkok Dusit Medical Services PCL

Last Price:
31.94
Seasonality Move:
0%

7 Day Trial

ALL ACCESS PASS

$ 7

Bangkok Dusit Medical Services PCL Price Quote

$31.94

Bangkok Dusit Medical Services PCL Key Stats

Sell
38
Bangkok Dusit Medical Services PCL (BDUUY) is a Sell
Day range:
$31.94 - $31.94
52-week range:
$30.15 - $32.49
Dividend yield:
2.41%
P/E ratio:
30.93
P/S ratio:
4.33
P/B ratio:
4.63%
Volume:
0
Avg. volume:
7
1-year change:
5.94%
Market cap:
$12.7B
Revenue:
$2.9B
EPS:
$1.05

How Much Does Bangkok Dusit Medical Services PCL Make?

Is Bangkok Dusit Medical Services PCL Growing As A Company?

Bangkok Dusit Medical Services PCL Stock Price Performance

What Is Bangkok Dusit Medical Services PCL 52-Week High & Low?

Bangkok Dusit Medical Services PCL Price To Free Cash Flow

Is It Risky To Buy Bangkok Dusit Medical Services PCL?

Is Bangkok Dusit Medical Services PCL Cash Flow Positive?

Bangkok Dusit Medical Services PCL Return On Invested Capital

  • Is Management Doing A Good Job?
    BDUUY return on invested capital is 14%
  • What Is Bangkok Dusit Medical Services PCL Return On Assets?
    ROA measures how assets are converting to revenues and is 10.67%
  • What Is BDUUY Return On Equity?
    ROE is a measure of profitability and is 15.64%

Bangkok Dusit Medical Services PCL Earnings Date & Stock Price

Bangkok Dusit Medical Services PCL Competitors

Bangkok Dusit Medical Services PCL Dividend Yield

Bangkok Dusit Medical Services PCL Analyst Estimates

YoY Growth Past Surprise
EPS: 12.1% 0%
Revenue: 5.13% 0%

Analyst Recommendations

Buy Recommendations: 0
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 0.00
Downside from Last Price: -100%

Major Shareholders

Data Unavailable